Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.

about

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells.

P2860

Q52571253-3BA5D3E0-904C-49A7-8F7D-76370215FB22

P2860

Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.

Item

http://www.wikidata.org/entity/Q38796925

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Enhanced antitumor efficacy of ...... vivo via transferrin binding.

@en

type

Item

label

Enhanced antitumor efficacy of ...... vivo via transferrin binding.

@en

prefLabel

Enhanced antitumor efficacy of ...... vivo via transferrin binding.

@en

P1476

Enhanced antitumor efficacy of ...... vivo via transferrin binding.

@en

P2093

Heqing Huang

http://www.w3.org/2001/XMLSchema#string

Hongwei Jin

http://www.w3.org/2001/XMLSchema#string

Huifang Peng

http://www.w3.org/2001/XMLSchema#string

Huiqin Zhuo

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2016

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer

EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer

Expression of the copper transporters hCtr1, ATP7A and ATP7B is associated with the response to chemotherapy and survival time in patients with resected non-small cell lung cancer.

Role of copper transporters in the uptake and efflux of platinum containing drugs.

Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy.

Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.

Biochemical mechanisms of cisplatin cytotoxicity.

Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination

The role of surface functionality in determining nanoparticle cytotoxicity

P304

45597-45611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17316

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28484093

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5542211

http://www.w3.org/2001/XMLSchema#string

Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.

about

P2860

P2860

Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932